Dr. Amarnath R. Vedere, MD

Dr. Vedere practices at Surgicath in Palm Beach Gardens, Florida.

Dr. Vedere's NPI, 1437141272, was assigned on August 18, 2005. Dr. Vedere graduated from Gandhi Medical College in 1986. Dr. Vedere holds Florida license ME0076025.

Dr. Vedere's primary practice is Surgicath, at 3345 Burns Rd, Ste 105-106, Palm Beach Gardens, FL 33410. The practice phone is (561) 790-8630.

Dr. Vedere's primary practice is Surgicath in Palm Beach Gardens, Florida. Dr. Vedere is also affiliated with Palm Beach Gardens Medical Center. The medical group on file is Cardiology Partners. Dmand AI also links Dr. Vedere to 4 more hospitals, 2 medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Vedere practices, 7 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Vedere's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Vedere is board certified in interventional cardiology by the American Board of Internal Medicine. Dmand AI has Dr. Vedere's licenses on file in 3 states: Florida, Michigan and Louisiana.

Dmand AI lists angioplasty, cardiac catheterization, leg revascularization, pacemaker or defibrillator implantation, pacemaker replacement and varicose vein treatment among the conditions Dr. Vedere treats.

CMS data shows 4,649 Medicare services from Dr. Vedere across 37 procedure codes in 2024, for 865 Medicare patients. Medicare paid $465,528 for them.

CMS counts 865 Medicare patients who saw Dr. Vedere in 2024. The largest group is 65 to 74, with 377 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 23% are also on Medicaid. Their average risk score is 1.80, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Vedere's median patient age at 67, with 50% women.

In 2024, Dr. Vedere wrote 4,540 Medicare Part D claims for 892 patients. 79% of them were for generic drugs. CMS names the drug for 4,270 of them, across 50 drugs with 11 or more claims each, at $926,418 in total drug cost. In 2023, CMS named 4,699 claims across 51 drugs.

Dr. Vedere accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Vedere as offering telehealth. CMS counts 18 procedures of varicose vein removal by Dr. Vedere, more than 55% of the clinicians it reports for that procedure.

Pacemaker insertion or repair: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links Dr. Vedere to 3 clinical trials. Conditions studied include Diabetes Mellitus, Type 2, Heart Failure and Peripheral Arterial Disease. Open Payments lists research payments to Dr. Vedere that name 1 trial.

CMS Open Payments shows 893 general payments to Dr. Vedere from 53 drug and device companies from 2016 to 2025. Education speaker fees make up the largest share, 62% of the total. Cardiovascular Systems Inc. paid the most, $26,447. It also lists 1 research payment totaling $9 in 2020, naming 1 clinical trial.

Dmand AI lists 1 award for Dr. Vedere.

Dr. Vedere graduated from Gandhi Medical College in 1986. Dr. Vedere is a member of ACC and The Society of Cardiovascular Angiography and Interventions.

Dr. Vedere is in network with 14 carriers, including Elevance, Aetna and Excellus BlueCross BlueShield. Medicare plans come from the most carriers, 12. Check the plan with the practice before a visit.